rasagiline ^Turanci (Q420685)

Daga Wikidata

Jump to navigation Jump to search

chemical compound ^Turanci

gyara

Language	Label	Description	Also known as
Hausa	Ba suna a kai	Ba'a bayyana ma'ana ba
Turanci	rasagiline	chemical compound	Azilect® TVP-1012 (R)-indan-1-yl-prop-2-ynyl-amine (1R)-N-propargylindan-1-amine (R)-N-2-Propynyl-1-indanamine RAS (1R)-N-Propargylindan-1-amine (R)-Indan-1-yl-prop-2-ynyl-amine Rasagiline

Statements

iri

type of chemical entity ^Turanci

0 references

Ƙaramin ɓangare na

unsaturated compound ^Turanci

0 references

amfani

magani

0 references

tsarin sinadaran

Rasagiline skeletal.svg
413 × 316; 7 KB

0 references

Taro

171.104799 dalton

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

3052776

harshen aiki ko suna

Turanci

laƙabi

rasagiline (Turanci)

retrieved ^Turanci

3 Oktoba 2016

mai ganowa ko mai ƙirƙira

Moussa B. H. Youdim ^Turanci

1 reference

adireshin manazarta

https://www.parkinson.org.il/%D7%90%D7%96%D7%99%D7%9C%D7%A7%D7%98-%D7%A8%D7%A1%D7%92%D7%99%D7%9C%D7%99%D7%9F-%D7%9E%D7%96%D7%99%D7%9C%D7%90%D7%98-%D7%9E%D7%99%D7%93%D7%A2-%D7%9E%D7%93%D7%A2%D7%99-%D7%A2%D7%9C-%D7%94%D7%AA/

stereoisomer of ^Turanci

N-Propargyl-1(S)-Aminoindan ^Turanci

2 references

based on heuristic ^Turanci

inferred from InChIKey ^Turanci

based on heuristic ^Turanci

inferred from InChI ^Turanci

sinadaran dabara

C₁₂H₁₃N

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

3052776

harshen aiki ko suna

Turanci

laƙabi

rasagiline (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

canonical SMILES ^Turanci

C#CCNC1CCC2=CC=CC=C12

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

3052776

harshen aiki ko suna

Turanci

laƙabi

rasagiline (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

isomeric SMILES ^Turanci

C#CCN[C@@H]1CCC2=CC=CC=C12

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

3052776

harshen aiki ko suna

Turanci

laƙabi

rasagiline (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

defined daily dose ^Turanci

1 milligram

route of administration ^Turanci

oral administration ^Turanci

1 reference

adireshin manazarta

https://www.whocc.no/atc_ddd_index/?code=N04BD02

active ingredient in ^Turanci

Azilect ^Turanci

1 reference

stated in ^Turanci

RxNorm ^Turanci

RxNorm ID ^Turanci

635985

retrieved ^Turanci

14 Faburairu 2018

Rasagiline Ratiopharm ^Turanci

1 reference

European Medicines Agency product number ^Turanci

EMEA/H/C/003957

adireshin manazarta

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003957/human_med_001836.jsp

retrieved ^Turanci

22 Maris 2017

World Health Organisation international non-proprietary name ^Turanci

rasagiline (Turanci)

1 reference

stated in ^Turanci

ChEBI ^Turanci

ChEBI ID ^Turanci

63620

harshen aiki ko suna

Turanci

laƙabi

rasagiline (Turanci)

retrieved ^Turanci

3 Oktoba 2016

medical condition treated ^Turanci

Cutar Parkinson

1 reference

stated in ^Turanci

Drug Indications Extracted from FAERS ^Turanci

retrieved ^Turanci

2 Oktoba 2018

significant drug interaction ^Turanci

bupropion ^Turanci

matsalar da zata iya haifarwa

hypertension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pethidine ^Turanci

matsalar da zata iya haifarwa

toxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

Tramadol

matsalar da zata iya haifarwa

toxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sertraline ^Turanci

matsalar da zata iya haifarwa

geniospasm ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sertraline ^Turanci

matsalar da zata iya haifarwa

mental status change ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sertraline ^Turanci

matsalar da zata iya haifarwa

hyperthermia ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sertraline ^Turanci

matsalar da zata iya haifarwa

hypertension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sumatriptan ^Turanci

matsalar da zata iya haifarwa

mental status change ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sumatriptan ^Turanci

matsalar da zata iya haifarwa

geniospasm ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sumatriptan ^Turanci

matsalar da zata iya haifarwa

hyperthermia ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sumatriptan ^Turanci

matsalar da zata iya haifarwa

hypertension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

frovatriptan ^Turanci

matsalar da zata iya haifarwa

mental status change ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

frovatriptan ^Turanci

matsalar da zata iya haifarwa

geniospasm ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

frovatriptan ^Turanci

matsalar da zata iya haifarwa

hyperthermia ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

frovatriptan ^Turanci

matsalar da zata iya haifarwa

hypertension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

vortioxetine ^Turanci

matsalar da zata iya haifarwa

hypertension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

vortioxetine ^Turanci

matsalar da zata iya haifarwa

Tachycardia

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

vortioxetine ^Turanci

matsalar da zata iya haifarwa

mental status change ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

vortioxetine ^Turanci

matsalar da zata iya haifarwa

hyperthermia ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

vortioxetine ^Turanci

matsalar da zata iya haifarwa

geniospasm ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

paroxetine ^Turanci

matsalar da zata iya haifarwa

hypertension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

paroxetine ^Turanci

matsalar da zata iya haifarwa

Tachycardia

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

paroxetine ^Turanci

matsalar da zata iya haifarwa

mental status change ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

paroxetine ^Turanci

matsalar da zata iya haifarwa

hyperthermia ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

paroxetine ^Turanci

matsalar da zata iya haifarwa

geniospasm ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

fluvoxamine ^Turanci

matsalar da zata iya haifarwa

hypertension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

fluvoxamine ^Turanci

matsalar da zata iya haifarwa

Tachycardia

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

fluvoxamine ^Turanci

matsalar da zata iya haifarwa

mental status change ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

fluvoxamine ^Turanci

matsalar da zata iya haifarwa

hyperthermia ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

fluvoxamine ^Turanci

matsalar da zata iya haifarwa

geniospasm ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

fluoxetine ^Turanci

matsalar da zata iya haifarwa

hypertension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

fluoxetine ^Turanci

matsalar da zata iya haifarwa

Tachycardia

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

fluoxetine ^Turanci

matsalar da zata iya haifarwa

mental status change ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

fluoxetine ^Turanci

matsalar da zata iya haifarwa

hyperthermia ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

fluoxetine ^Turanci

matsalar da zata iya haifarwa

geniospasm ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-citalopram ^Turanci

matsalar da zata iya haifarwa

hypertension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-citalopram ^Turanci

matsalar da zata iya haifarwa

Tachycardia

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-citalopram ^Turanci

matsalar da zata iya haifarwa

mental status change ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-citalopram ^Turanci

matsalar da zata iya haifarwa

hyperthermia ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-citalopram ^Turanci

matsalar da zata iya haifarwa

geniospasm ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

linezolid ^Turanci

matsalar da zata iya haifarwa

muscle stiffness ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

linezolid ^Turanci

matsalar da zata iya haifarwa

seizure ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

linezolid ^Turanci

matsalar da zata iya haifarwa

palpitation ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

linezolid ^Turanci

matsalar da zata iya haifarwa

hypertensive crisis ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

linezolid ^Turanci

matsalar da zata iya haifarwa

headache disorder ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

levodopa ^Turanci

matsalar da zata iya haifarwa

orthostatic hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ta jiki ma'amala da

Monoamine oxidase B ^Turanci

subject has role ^Turanci

enzyme inhibitor ^Turanci

1 reference

stated in ^Turanci

IUPHAR/BPS Guide to PHARMACOLOGY ^Turanci

Guide to Pharmacology Ligand ID ^Turanci

6641

harshen aiki ko suna

Turanci

retrieved ^Turanci

17 Agusta 2016

route of administration ^Turanci

oral administration ^Turanci

0 references

pregnancy category ^Turanci

Australian pregnancy category B3 ^Turanci

1 reference

an ɗauko daga

English Wikipedia ^Turanci

US pregnancy category C ^Turanci

1 reference

an ɗauko daga

English Wikipedia ^Turanci

LiverTox likelihood score ^Turanci

LiverTox toxicity likelihood category E ^Turanci

1 reference

stated in ^Turanci

LiverTox ^Turanci

retrieved ^Turanci

8 Afirilu 2021

adireshin manazarta

https://www.ncbi.nlm.nih.gov/books/n/livertox/Rasagiline

last update ^Turanci

21 Yuli 2017

subject has role ^Turanci

monoamine oxidase inhibitor ^Turanci

2 references

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

N0000171790

retrieved ^Turanci

5 Maris 2018

stated in ^Turanci

Medical Subject Headings ^Turanci

MeSH descriptor ID ^Turanci

C031967

retrieved ^Turanci

15 Maris 2018

neuroprotective agent ^Turanci

1 reference

stated in ^Turanci

Medical Subject Headings ^Turanci

MeSH descriptor ID ^Turanci

C031967

retrieved ^Turanci

15 Maris 2018

Commons category ^Turanci

Rasagiline

0 references

Identifiers

InChI ^Turanci

InChI=1S/C12H13N/c1-2-9-13-12-8-7-10-5-3-4-6-11(10)12/h1,3-6,12-13H,7-9H2/t12-/m1/s1

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

3052776

harshen aiki ko suna

Turanci

laƙabi

rasagiline (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

InChIKey ^Turanci

RUOKEQAAGRXIBM-GFCCVEGCSA-N

2 references

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

3052776

harshen aiki ko suna

Turanci

laƙabi

rasagiline (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

stated in ^Turanci

ChEBI release 2020-09-01 ^Turanci

CAS Registry Number ^Turanci

136236-51-6

2 references

stated in ^Turanci

Global Substance Registration System ^Turanci

UNII ^Turanci

003N66TS6T

harshen aiki ko suna

Turanci

laƙabi

rasagiline (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

InChIKey ^Turanci

RUOKEQAAGRXIBM-GFCCVEGCSA-N

stated in ^Turanci

CAS Common Chemistry ^Turanci

retrieved ^Turanci

10 Afirilu 2021

adireshin manazarta

https://commonchemistry.cas.org/detail?cas_rn=136236-51-6

ChemSpider ID ^Turanci

2314553

1 reference

stated in ^Turanci

ChemSpider ^Turanci

ChemSpider ID ^Turanci

2314553

harshen aiki ko suna

Turanci

laƙabi

Rasagiline (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

PubChem CID ^Turanci

3052776

2 references

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

3052776

harshen aiki ko suna

Turanci

laƙabi

rasagiline (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

matched by identifier from ^Turanci

InChIKey

InChIKey ^Turanci

RUOKEQAAGRXIBM-GFCCVEGCSA-N

Reaxys registry number ^Turanci

9194207

1 reference

stated in ^Turanci

ChEBI ^Turanci

ChEBI ID ^Turanci

63620

harshen aiki ko suna

Turanci

laƙabi

rasagiline (Turanci)

retrieved ^Turanci

3 Oktoba 2016

ChEBI ID ^Turanci

63620

mapping relation type ^Turanci

exact match ^Turanci

2 references

stated in ^Turanci

ChEMBL ^Turanci

ChEMBL ID ^Turanci

CHEMBL887

harshen aiki ko suna

Turanci

laƙabi

RASAGILINE (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

matched by identifier from ^Turanci

International Chemical Identifier ^Turanci

InChI ^Turanci

InChI=1S/C12H13N/c1-2-9-13-12-8-7-10-5-3-4-6-11(10)12/h1,3-6,12-13H,7-9H2/t12-/m1/s1

ChEMBL ID ^Turanci

CHEMBL887

1 reference

stated in ^Turanci

ChEMBL ^Turanci

ChEMBL ID ^Turanci

CHEMBL887

harshen aiki ko suna

Turanci

laƙabi

RASAGILINE (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

SureChEMBL ID ^Turanci

SCHEMBL74699

2 references

based on heuristic ^Turanci

inferred from InChIKey ^Turanci

matched by identifier from ^Turanci

InChIKey

InChIKey ^Turanci

RUOKEQAAGRXIBM-GFCCVEGCSA-N

UniChem compound ID ^Turanci

473512

1 reference

stated in ^Turanci

UniChem ^Turanci

HSDB ID ^Turanci

7699

1 reference

stated in ^Turanci

Hazardous Substances Data Bank ^Turanci

HSDB ID ^Turanci

7699

ranar wallafa

28 Oktoba 2019

laƙabi

RASAGILINE (Turanci)

retrieved ^Turanci

10 Mayu 2021

DSSTox substance ID ^Turanci

DTXSID3041112

2 references

stated in ^Turanci

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard ^Turanci

matched by identifier from ^Turanci

InChIKey

InChIKey ^Turanci

RUOKEQAAGRXIBM-GFCCVEGCSA-N

DSSTOX compound identifier ^Turanci

DTXCID1021112

0 references

LiverTox ID ^Turanci

Rasagiline

0 references

NSC number ^Turanci

759639

0 references

ECHA Substance Infocard ID ^Turanci

100.301.709

0 references

Lambar ATC

N04BD02

1 reference

stated in ^Turanci

DrugBank ^Turanci

DrugBank ID ^Turanci

01367

harshen aiki ko suna

Turanci

laƙabi

Rasagiline (Turanci)

ranar wallafa

17 Nuwamba 2015

Guide to Pharmacology Ligand ID ^Turanci

6641

1 reference

stated in ^Turanci

IUPHAR/BPS Guide to PHARMACOLOGY ^Turanci

Guide to Pharmacology Ligand ID ^Turanci

6641

harshen aiki ko suna

Turanci

laƙabi

rasagiline (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

MeSH descriptor ID ^Turanci

C031967

1 reference

stated in ^Turanci

Medical Subject Headings ^Turanci

MeSH descriptor ID ^Turanci

C031967

retrieved ^Turanci

14 Maris 2018

RxNorm ID ^Turanci

134748

1 reference

stated in ^Turanci

Global Substance Registration System ^Turanci

UNII ^Turanci

003N66TS6T

harshen aiki ko suna

Turanci

laƙabi

rasagiline (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

DrugBank ID ^Turanci

DB01367

1 reference

matched by identifier from ^Turanci

InChIKey

InChIKey ^Turanci

RUOKEQAAGRXIBM-GFCCVEGCSA-N

Human Metabolome Database ID ^Turanci

HMDB0015454

2 references

based on heuristic ^Turanci

inferred from InChIKey ^Turanci

matched by identifier from ^Turanci

InChIKey

InChIKey ^Turanci

RUOKEQAAGRXIBM-GFCCVEGCSA-N

UNII ^Turanci

003N66TS6T

2 references

stated in ^Turanci

Global Substance Registration System ^Turanci

UNII ^Turanci

003N66TS6T

harshen aiki ko suna

Turanci

laƙabi

rasagiline (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

matched by identifier from ^Turanci

InChIKey

InChIKey ^Turanci

RUOKEQAAGRXIBM-GFCCVEGCSA-N

MedlinePlus drug identifier ^Turanci

a606017

0 references

PatientsLikeMe treatment ID ^Turanci

rasagiline

0 references

NDF-RT ID ^Turanci

N0000171790

1 reference

stated in ^Turanci

Global Substance Registration System ^Turanci

UNII ^Turanci

003N66TS6T

harshen aiki ko suna

Turanci

laƙabi

rasagiline (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

Probes And Drugs ID ^Turanci

PD009528

0 references

DrugCentral ID ^Turanci

3521

1 reference

stated in ^Turanci

UniChem ^Turanci

KEGG ID ^Turanci

D08469

1 reference

stated in ^Turanci

ChEBI ^Turanci

ChEBI ID ^Turanci

63620

harshen aiki ko suna

Turanci

laƙabi

rasagiline (Turanci)

retrieved ^Turanci

3 Oktoba 2016

PDB ligand ID ^Turanci

RAU

0 references

Freebase ID ^Turanci

/m/0f00c4

1 reference

stated in ^Turanci

Freebase Data Dumps ^Turanci

ranar wallafa

28 Oktoba 2013

Microsoft Academic ID ^Turanci

2781249495

0 references

OpenAlex ID ^Turanci

C2781249495

1 reference

stated in ^Turanci

OpenAlex ^Turanci

retrieved ^Turanci

26 Janairu 2022

adireshin manazarta

https://docs.openalex.org/download-snapshot/snapshot-data-format

UMLS CUI ^Turanci

C0525678

1 reference

stated in ^Turanci

Global Substance Registration System ^Turanci

UNII ^Turanci

003N66TS6T

harshen aiki ko suna

Turanci

laƙabi

rasagiline (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

WikiProjectMed ID ^Turanci

Rasagiline

0 references

 

Sitelinks

Wikipedia(22 entries)

gyara

• arwiki راساجيلين
• dewiki Rasagilin
• enwiki Rasagiline
• eswiki Rasagilina
• fawiki رازاژیلین
• fiwiki Rasagiliini
• frwiki Rasagiline
• hewiki רסג'ילין
• itwiki Rasagilina
• jawiki ラサギリン
• lawiki Rasagilinum
• nlwiki Rasagiline
• orwiki ରାସାଗିଲିନ
• ptwiki Rasagilina
• rowiki Rasagilină
• ruwiki Разагилин
• shwiki Rasagilin
• srwiki Rasagilin
• svwiki Rasagilin
• trwiki Rasajilin
• ukwiki Разагілін
• zhwiki 雷沙吉兰

Wikibooks(0 entries)

gyara

Wikinews(0 entries)

gyara

Wikiquote(0 entries)

gyara

Wikisource(0 entries)

gyara

Wikiversity(0 entries)

gyara

Wikivoyage(0 entries)

gyara

Wiktionary(0 entries)

gyara

Wasu shafuka(1 entry)

gyara

• commonswiki Category:Rasagiline

Daga "https://www.wikidata.org/w/index.php?title=Q420685&oldid=2211519794"